FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, and represents a bioengineered collagen construct for reconstruction or replacement of damaged tissue, characterised by the fact that it comprises a layer of a purified collagen tissue matrix taken from the small intestinal submucosa, wherein said purified collagen tissue matrix is processed by a pharmaceutically acceptable antimicrobial agent and has the anti-microbial properties.
EFFECT: invention provides the bioengineered collagen construct with the improved antimicrobial properties.
17 cl, 11 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOENGINEERED CONSTRUCT FOR TISSUE IMPLANTATION AND METHOD FOR MAKING SAID BIOENGINEERED CONSTRUCT (VERSIONS) | 2008 |
|
RU2461622C2 |
| COLLAGEN SPONGE | 2015 |
|
RU2672593C1 |
| TISSUE STRUCTURES OBTAINED BY BIOENGINEERING, AND METHODS FOR THEIR PRODUCTION AND APPLICATION | 2011 |
|
RU2645473C2 |
| TISSUE REGENERATION METHOD AND MEMBRANE | 2010 |
|
RU2532370C2 |
| METHOD OF POROUS COLLAGEN MATRIX PRODUCTION | 2023 |
|
RU2808686C1 |
| METHOD OF TREATING PATIENT'S ORAL DISEASES (VERSIONS) | 2007 |
|
RU2498808C9 |
| METHOD FOR TENDON OR LIGAMENT RECONSTRUCTION | 2013 |
|
RU2629809C2 |
| METHOD FOR OBTAINING COLLAGEN MATERIAL AND MULTILAYER COLLAGEN MEMBRANES FOR SURGERY | 2021 |
|
RU2773529C1 |
| METHOD OF PREVENTION OR TREATMENT OF REDUCTION OF ACCESS FOR VESSEL HEMODIALYSIS AND DEVICE FOR ITS REALISATION AND OTHER VASCULAR GRAFTS | 2002 |
|
RU2345719C2 |
| OCCLUDER FOR TRANSCUTANEOUS TRANSLUMINAL PROCEDURE (VERSIONS), METHOD OF TRANSCUTANEOUS TRANSLUMINAL CLOSING OF HOLE IN HEART, METHOD OF ACTIVISATION OF MAMMALIAN TISSUE VASCULARISATION IN VIVO AND METHOD OF ACTIVISATION OF ANASTOMOSIS PLACE HEALING | 2007 |
|
RU2470611C2 |
